ACCEL RESEARCH SITES NETWORK Trademark

Trademark Overview


On Monday, May 1, 2023, a trademark application was filed for ACCEL RESEARCH SITES NETWORK with the United States Patent and Trademark Office. The USPTO has given the ACCEL RESEARCH SITES NETWORK trademark a serial number of 97915045. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, May 13, 2024. This trademark is owned by Clinical Research Holdings, LLC. The ACCEL RESEARCH SITES NETWORK trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Business consulting and management in the field of clinical trials in all phases as it relates to pre-study document collection and review, site selection, visits and audits, site compliance, project tracking and monitoring reports, negotiation and administration of investigator grants and clinical trial budgets and contracts, financial and management accounting, distribution, coordination and tracking of clinical trial products and materials, regulatory document processing, laboratory selection and coordination; Business consulting and management in the field of clinical trials in all phases as it relates to managing site and study-specific subject recruitment strategies and programs in the nature of contingency strategies and solutions to address specific project challenges; Business consulting and management in the field of clinical trials in all phases as it relates to managing the development of all study related documents and materials in the nature of study protocols, contracts,...

Regulatory affairs, namely, reviewing standards and practices to assure compliance with clinical trial laws and regulations; Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research

Medical and scientific research consulting services for others in the field of design, planning, and implementation of clinical trials in all phases; providing quality assurance services in the pharmaceutical and biotechnological industries
accel research sites network

General Information


Serial Number97915045
Word MarkACCEL RESEARCH SITES NETWORK
Filing DateMonday, May 1, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, May 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBusiness consulting and management in the field of clinical trials in all phases as it relates to pre-study document collection and review, site selection, visits and audits, site compliance, project tracking and monitoring reports, negotiation and administration of investigator grants and clinical trial budgets and contracts, financial and management accounting, distribution, coordination and tracking of clinical trial products and materials, regulatory document processing, laboratory selection and coordination; Business consulting and management in the field of clinical trials in all phases as it relates to managing site and study-specific subject recruitment strategies and programs in the nature of contingency strategies and solutions to address specific project challenges; Business consulting and management in the field of clinical trials in all phases as it relates to managing the development of all study related documents and materials in the nature of study protocols, contracts, budgets, amendments, paper and electronic case report forms, informed consent forms, safety narratives, presentation posters, and training manuals; Business consulting and management in the field of clinical trials in all phases as it relates to managing all aspects of study, drug reconciliation, and inventory and distribution reports; Business management for all aspects of clinical trials in all phases as it relates to managing investigators, coordinators, monitors, technicians, and participants for compliance with clinical protocols and regulations; Business consulting and management in the field of clinical trials in all phases as it relates to management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials in all phases as it relates to ethical reviews, namely, submitting clinical trial protocols to institutional review boards and independent ethics committees on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical trials; Statistical analysis and reporting services for business purposes in the field of clinical trials; Business project management in the field of clinical trials in all phases as it relates to organizing and conducting business meetings of clinical trial investigators; Business management, namely, managing randomization logistics, in the pharmaceutical and biotechnological field for business purposes; Development and implementation of personnel recruitment and retention programs for investigators, coordinators, monitors, technicians and participants for use in clinical trials; Business consulting and management in the field of clinical trials in all phases as it relates to the administration of protocols involving volunteer research patients and the recruiting of such volunteer research patients; Providing data management services in the medical, pharmaceutical and biotechnological field for business purposes
Goods and ServicesRegulatory affairs, namely, reviewing standards and practices to assure compliance with clinical trial laws and regulations; Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research
Goods and ServicesMedical and scientific research consulting services for others in the field of design, planning, and implementation of clinical trials in all phases; providing quality assurance services in the pharmaceutical and biotechnological industries

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, May 30, 2023
Primary Code035
First Use Anywhere DateMonday, October 31, 2022
First Use In Commerce DateMonday, October 31, 2022

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 30, 2023
Primary Code042
First Use Anywhere DateMonday, October 31, 2022
First Use In Commerce DateMonday, October 31, 2022

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 30, 2023
Primary Code045
First Use Anywhere DateMonday, October 31, 2022
First Use In Commerce DateMonday, October 31, 2022

Trademark Owner History


Party NameClinical Research Holdings, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLake Mary, FL 32746

Trademark Events


Event DateEvent Description
Tuesday, May 30, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 26, 2024ASSIGNED TO EXAMINER
Friday, January 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 4, 2023NEW APPLICATION ENTERED
Friday, January 26, 2024NON-FINAL ACTION WRITTEN
Friday, January 26, 2024NON-FINAL ACTION E-MAILED
Monday, January 29, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 29, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 29, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 13, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, May 13, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE